Rightview
Rightview is an AI-powered clinical research operations platform that automates trial workflows for CROs, sponsors, and clinical sites. The platform provides cited answers from study documents, automated source review, pre-screening, and amendment management, with every action requiring human approval. It reports 8–20× faster source review and 5× more source issues caught than human reviewers across 60+ live studies.
- Artificial Intelligence
- Healthcare Technology
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Drug development operations rarely fit off-the-shelf software, forcing clinical trial teams to bend their processes around rigid products. Teams on the frontlines of drug development face persistent operational bottlenecks that slow trial execution and demand both precision and speed, yet available technology solutions are not tailored to their specific workflows.
Solution
Rightview brings cutting-edge AI and in-house experts to the most innovative teams across drug development, providing a hands-on partnership from first conversation to delivery. The company works alongside client teams to shape technology around the problems they actually need solved, rather than forcing them to adapt to a predefined product. Rightview staff sit beside clients throughout the engagement, contributing people who know drug development firsthand instead of a support queue. The company handles the heavy lifting end to end so client teams stay focused on the science and the patients it serves, building custom solutions for clinical data workflows and trial operations.
Target Audience
Primary customers are clinical trial sites, life science organizations, and biopharma service providers across the drug development lifecycle who need tailored AI-driven technology solutions for regulated environments.
Features
- Custom-built technology tailored to each client's specific drug development workflow rather than off-the-shelf software
- In-house experts with firsthand drug development experience embedded alongside client teams
- End-to-end delivery model covering the full implementation cycle from initial conversation to deployment
- CFR 21 Part 11 compliant platform with full audit trails, e-signature support, and access controls
- Enterprise-grade infrastructure designed for regulated clinical environments
- Engagement model spans clinical trial sites, life science organizations, and biopharma service providers across the drug development lifecycle